Cart
sales@molnova.com
I-XW-053
CAS No. 5496-35-5
I-XW-053 ( I XW 053; IXW053; 4-(4,5-Diphenyl-1H-iMidazol-2-yl)benzoic Acid )
Catalog No. M27211 CAS No. 5496-35-5
I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 500MG | 482 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameI-XW-053
-
NoteResearch use only, not for human use.
-
Brief DescriptionI-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
-
DescriptionI-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
-
SynonymsI XW 053; IXW053; 4-(4,5-Diphenyl-1H-iMidazol-2-yl)benzoic Acid
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorSmoothened
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5496-35-5
-
Formula Weight340.4
-
Molecular FormulaC22H16N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccc1)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Manetti F, et al. Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives. Eur J Med Chem. 2016;121:747-757.
molnova catalog
related products
-
(±)-BI-D
A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase.
-
Escin IA;Aescin IA
Escin IA is a triterpene saponin isolated from horse chestnut which inhibits HIV-1 protease with IC50 values of 35 μM. Escin IA has anti-TNBC metastasis activity and its action mechanisms involved inhibition of epithelial-mesenchymal transition process by down-regulating LOXL2 expression.
-
GS-9695
GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
